Literature DB >> 16410802

Signals from within: the DNA-damage-induced NF-kappaB response.

S Janssens1, J Tschopp.   

Abstract

An appropriate response to genotoxic stress is essential for maintenance of genome stability and avoiding the passage to neoplasia. Nuclear factor kappaB (NF-kappaB) is activated as part of the DNA damage response and is thought to orchestrate a cell survival pathway, which, together with the activation of cell cycle checkpoints and DNA repair, allows the cell in cases of limited damage to restore a normal life cycle, unharmed. In this respect, NF-kappaB is one of the main factors accounting for chemotherapy resistance and as such impedes effective cancer treatment, representing an important drug target. Despite this high clinical relevance, signalling cascades leading to DNA damage-induced NF-kappaB activation are poorly understood and the use of highly divergent experimental set-ups in the past led to many controversies in the field. Therefore, in this review, we will try to summarize the current knowledge of distinct DNA damage-induced NF-kappaB signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410802     DOI: 10.1038/sj.cdd.4401843

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  114 in total

1.  Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner.

Authors:  B L Probst; L Liu; V Ramesh; L Li; H Sun; J D Minna; L Wang
Journal:  Cell Death Differ       Date:  2010-04-30       Impact factor: 15.828

Review 2.  Signaling to NF-kappaB: regulation by ubiquitination.

Authors:  Ingrid E Wertz; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 3.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 4.  Combination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunities.

Authors:  Charlie Garnett-Benson; James W Hodge; Sofia R Gameiro
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 5.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

6.  Phosphorylation of IκBα at serine 32 by T-lymphokine-activated killer cell-originated protein kinase is essential for chemoresistance against doxorubicin in cervical cancer cells.

Authors:  Jung-Hwan Park; Dae-Sung Yoon; Hye-Jin Choi; Dae-Hyun Hahm; Sang-Muk Oh
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

7.  RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair.

Authors:  Jingxin Wang; Naduparambil K Jacob; Katherine J Ladner; Amer Beg; James D Perko; Stephan M Tanner; Sandya Liyanarachchi; Richard Fishel; Denis C Guttridge
Journal:  EMBO Rep       Date:  2009-09-25       Impact factor: 8.807

8.  Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency.

Authors:  Sung-Yun Pai; Ofer Levy; Haifa H Jabara; Jonathan N Glickman; Liat Stoler-Barak; Jessica Sachs; Samuel Nurko; Jordan S Orange; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

9.  Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.

Authors:  Nicole M Mackey-Lawrence; Xiaoti Guo; Daniel E Sturdevant; Kimmo Virtaneva; Matthew M Hernandez; Eric Houpt; Alan Sher; Stephen F Porcella; William A Petri
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Quantitative proteomics reveal ATM kinase-dependent exchange in DNA damage response complexes.

Authors:  Serah Choi; Rohith Srivas; Katherine Y Fu; Brian L Hood; Banu Dost; Gregory A Gibson; Simon C Watkins; Bennett Van Houten; Nuno Bandeira; Thomas P Conrads; Trey Ideker; Christopher J Bakkenist
Journal:  J Proteome Res       Date:  2012-09-18       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.